A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
Titel:
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
Auteur:
Flowers, Christopher R. Brown, Jennifer R. Rosenthal, Hilary Stock, Wendy Katzen, Harvey I. Cohen, Jonathon B. Sinha, Rajni Lakhanpal, Shailendra Leis, Jose F. Waller, Edmund K. Jaye, David L.